Berberine compounds improves hyperglycemia via microbiome mediated colonic TGR5-GLP pathway in db/db mice - 18/11/20
páginas | 9 |
Iconografías | 7 |
Vídeos | 0 |
Otros | 0 |
Graphical abstract |
Highlights |
• | BC improves hyperglycemia and dyslipidemia in db/db mice. |
• | BC promotes DCA production via modulating gut microbiota, and activates colonicTGR5-GLP pathway in db/db mice. |
• | BC mediated TGR5-GLP pathway may affect metabolites that involved in glucose, lipid and energy metabolism in db/db mice. |
Abstract |
Berberine compounds (BC), consisting of berberine (BBR), oryzanol and vitamin B6, have been used to treat diabetes and hyperlipidemia in recent years, but the potential mechanisms under the effects have not been well determined. In this study, we evaluated the effect of BC in db/db mice, and found that BC treatment reversed the increased levels of fasting glucose and hemoglobin A1c in db/db mice, which was superior to BBR treatment. Fecal 16S rRNA gene sequencing indicated that BC increased relative abundance of microbiomes Bacteroidaceae and Clostridiaceae, which may promote conversion of primary bile acid cholic acid (CA) into secondary bile acid deoxycholic acid (DCA). Gas chromatography/mass spectrometry (GC/MS)-based metabolomics revealed that BC treatment increased fecal DCA level. Since DCA processes the potential to activate bile acid receptor-takeda G protein-coupled receptor 5 (TGR5) and induce glucagon-like peptide (GLP) secretion, we detected TGR5 expression, and found that BC-treatment significantly increased the colonic TGR5 and serum GLP-1/-2 levels in db/db mice. Modulation of TGR5-GLP pathway may also affect metabolomic profiles of serum and liver, and BC treatment showed effects on restoring the altered carbohydrate, lipid, amino acid and nucleotide metabolism. Our study suggested that BC improved hyperglycemia, the effect might attribute to the increased microbiome mediated DCA production, which up-regulated colonic TGR5 expression and GLP secretion, and improved glucose, lipid and energy metabolism in db/db mice.
El texto completo de este artículo está disponible en PDF.Abbreviations : BBR, BC, BSH, CA, DCA, FFAs, GC/MS, GLP, HbA1c, HDL-c, LDL-c, NMDS, T2DM, OPLS-DA, OTUs, PCA, PCoA, PVDF, RIPA, TC, TG, TGR5, TMCS
Keywords : Berberine compounds, Hyperglycemia, Gut microbiota, Deoxycholic acid, Takeda G protein-coupled receptor 5, Glucagon-like peptide
Esquema
Vol 132
Artículo 110953- décembre 2020 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
La compra de artículos no está disponible en este momento.
¿Ya suscrito a @@106933@@ revista ?